A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

"We are excited to have completed administering first doses to all patients enrolled in our phase 2 Alzheimer's trial,” ...

Recent research has revealed that alcohol use disorder and Alzheimer’s disease share significant patterns of gene ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

and patient outcomes. From advanced imaging to AI-driven analysis, we seek studies that not only push the boundaries of what is possible but also directly address the clinical needs of conditions such ...

Whether these departments get the money will be decided later, but the Scene listened in on requests from the Department of ...

For now, after obtaining approval for early stages of cognitive decline and dementia, lecanemab and donanemab continue their ...

Without a patient having to wait to see a specialist, the robot can run approximately 3.9 million tests per year on a ...

TOKYO (Kyodo) -- A single course of newly approved Alzheimer's drug donanemab-azbt ... The drug developed by U.S.

(JAMA Network Open) How should clinicians manage comatose patients with epileptiform abnormalities after ... (Neurology: ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...